Treatment Options When GLP-1 Medications Are Not Tolerated When a patient cannot tolerate GLP-1 therapy, the next step is evaluating other weight-management strategies
Because some people have already lost weight on injectable GLP-1 medications and need a maintenance option that does not require ongoing injections
Inflammatory response to liraglutide was investigated on human THP-1 macrophages (later polarized into M0,M1,M2 macrophages) and bone marrow-derived macrophages, from both wild-type C57BL/6 (WT) and apolipoprotein E null mice (apoE/)
Semaglutide is one of the most widely prescribed GLP-1 medications for chronic weight management
Current Status (2026) Retatrutide remains under clinical investigation and is progressing through large Phase 3 trials for obesity and related metabolic conditions
For All of South Florida: Available in Miami, Fort Lauderdale, Boca Raton, and West Palm Beach